A multi-centre study on cervical cancer screening reveals population-related impact on cervical intraepithelial neoplasia rate
Authors:
Open Access
- 28 September 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 16, 1920297
Abstract
Objective: To conduct a three-year cervical cancer screen in Zhejiang, Sichuan, Beijing, and Inner Mongolia and analyse clinical and population data to identify possible improvements to the screening protocol. Methods: A standard protocol including human papillomavirus (HPV) detection, cytology test, colposcopy, and histopathology inspection was adapted for the screening. Additional HPV genotyping was performed for participants in Sichuan, Beijing, and Inner Mongolia. Results: 12,086 women were included in this study, and 178 cases of cervical intraepithelial neoplasia (CIN) grade 2 or worse (CIN2+) were identified. Detailed analyses on features of age, region, ethnicity, and origin showed a notable correlation between age strata and high-grade CIN rates. Moreover, apart from HPV16/18, other HPV types such as HPV33, HPV52, and HPV58 were found to be enriched in high-grade CIN cases, as was repeat positivity. Conclusions: Our results suggest that age, HPV16, and ThinPrep cytologic test (TCT) are prominent exploratory predictors for CIN2+ detection, and HPV33, 52, and 58 may pose higher risks than other non-HPV16/18 types. Future studies incorporating prospective effectiveness and health-economic evaluation are required to validate the clinical utility of these predictors.Keywords
Funding Information
- National Key Research and Development Program of China
This publication has 28 references indexed in Scilit:
- Whole‐genome sequencing of 1,083 HPV45 cases and controls identifies genetic variants associated with glandular cervical lesionsInternational Journal of Cancer, 2025
- HPV integration and cervical cancer: a failed evolutionary viral traitTrends in Molecular Medicine, 2024
- Guidelines for cervical cancer screening in ChinaGynecology and Obstetrics Clinical Medicine, 2023
- Cervical Cancer ScreeningJAMA, 2023
- Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by regionPapillomavirus Research, 2016
- Cervical cancer screening: evidence behind the guidelinesAmerican Journal of Obstetrics and Gynecology, 2016
- Age and geographic variability of human papillomavirus high-risk genotype distribution in a large unvaccinated population and of vaccination impact on HPV prevalenceJournal of Clinical Virology, 2014
- The influence of type‐specific human papillomavirus infections on the detection of cervical precancer and cancer: A population‐based study of opportunistic cervical screening in the United StatesInternational Journal of Cancer, 2013
- Human papillomavirus and cervical cancerThe Lancet, 2013
- Screening interval and risk of invasive squamous cell cervical cancerObstetrics & Gynecology, 2003